Home Your basket
• Thyroid surgery (356 case...
   Price 10.50 €
• Predictive factors for su...
   Price 15.00 €
• Therapeutic management of...
   Price 10.50 €
• Parapharyngeal lymph node...
   Price 8.50 €
• Genotype – phenotype corr...
   Price 8.50 €
• Cervical liposuction: A r...
   Price 10.50 €
• Smile "forced" smile vers...
   Price 10.50 €
• Stuttering and Tourette’s...
   Price 5.50 €
• Side effects and patients...
   Price 10.50 €
• Transverse maxillary defi...
   Price 8.50 €
• The «neurological» velum ...
   Price 14.00 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Context influence on the ...
   Price 10.50 €
• Auditory screening in neo...
   Price 8.50 €
• Surgical treatement by in...
   Price 12.50 €
• Evaluation of vocal abuse...
   Price 8.50 €
• Treatment of severe epist...
   Price 5.50 €
• Termino-terminal hypoglos...
   Price 10.50 €
• Endobronchial lipomas and...
   Price 5.50 €
• Facial dissection applied...
   Price 14.00 €
• Laryngeal tuberculosis....
   Price 8.50 €
• Thyroid differenciated ca...
   Price 10.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• Early ENT manifestations ...
   Price 10.50 €
• Ruptured pexis after supr...
   Price 10.50 €
• When some clinical cases ...
   Price 8.50 €
• Predictive factors for re...
   Price 14.00 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Turner syndrome audiologi...
   Price 12.00 €
• A protocol for the evalua...
   Price 8.50 €
• Nasal glioma, diagnosis i...
   Price 12.00 €
• Rhinitis and allergy test...
   Price 8.50 €
• A case of laryngeal sialo...
   Price 10.50 €
• Bilateral vestibular loss...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Anosmia following superio...
   Price 5.50 €
• Laryngeal cryptococcosis ...
   Price 8.50 €
• Histology of the larynx....
   Price 8.50 €
• The expanding domain of i...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Ossicular reconstruction ...
   Price 10.50 €
• Modified butterfly cartil...
   Price 10.50 €
• Apology for the biplane c...
   Price 10.50 €
• Tympanoplasty: Experience...
   Price 12.00 €
• Comparison of three diffe...
   Price 12.00 €
• The velum: 5th tap of spe...
   Price 14.00 €
• Bilateral latero-pontine ...
   Price 5.50 €
• Evaluation of a dysphonic...
   Price 10.50 €
• Laryngeal papillomatosis ...
   Price 5.50 €
• Migrating hypopharyngeal ...
   Price 5.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• Comparative results of ty...
   Price 10.50 €
• Tuberculosis of the parot...
   Price 5.50 €
• Are we sectioning the coc...
   Price 10.50 €
• Silent Sinus Syndrome – T...
   Price 8.50 €
• Congenital anomalies of n...
   Price 14.00 €
• Adolescence and cochlear ...
   Price 10.50 €
• Revision ossiculoplasty: ...
   Price 10.50 €
• Decompression surgery for...
   Price 8.50 €
• Bilateral and recurrent f...
   Price 5.50 €
• Alternative clinical mana...
   Price 10.50 €
• Antro choanal polyp in ch...
   Price 10.00 €
• Sinonasal hemangiopericyt...
   Price 10.50 €
• Parapharyngeal tumours: M...
   Price 10.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Peritonsillar abscess: Is...
   Price 10.50 €
• Stuttering of the “Miror”...
   Price 5.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Papillary thyroid carcino...
   Price 10.50 €
• Otomycosis due to Scopula...
   Price 10.50 €
• Nasal polyposis: long ter...
   Price 10.50 €
• Endoscopic anatomy of the...
   Price 10.50 €
• Comparison of stapes prot...
   Price 15.00 €
• Is it possible to evolve ...
   Price 8.50 €
• New indications for heari...
   Price 8.50 €
• Giant metastasis invading...
   Price 5.50 €
• Management of free-flap f...
   Price 14.00 €

Total Order 742.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 2000 o

OTONEUROLOGY

The natural history of untreated vestibular schwannomas. Is there a role for conservative management ?


Authors : R. M. Walsh, A. P. Bath, M. L. Bance, A. Keller, C. H. Tator, J. A. Rutka (Toronto)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,1:21-26.

Article published in english



Summary : Objective: the aim of this study was to investigate the natural history and outcome following the conservative management of a group of patients with unilateral vestibular schwannomas. Methods: 72 patients with a radiological diagnosis of unilateral vestibular schwannoma were managed conservatively because of poor general health, advanced age, patient preference, small tumour size, minimal symptoms, or tumour in the only / better hearing ear. All patients underwent serial magnetic resonance imaging for assessment of tumour growth, according to American Academy of Otolaryngology-Head & Neck Surgery guidelines (1995). The mean duration of follow-up was 37.8 months (range 12-194 months). Patients were deemed to have failed conservative management if there was evidence of continuous or rapid radiological tumour growth, and / or increasing symptoms or signs. Results : the mean tumour growth rate was 1.16 mm/year (range -0.75 to 9.65 mm/year). Approximately 83% of tumours grew at less than 2 mm/year. Significant tumour growth (total growth > 1 mm) was seen in 36.4%, no or insignificant growth (0 - 1 mm) in 50%, and negative growth (< 0 mm) in 13.6% of tumours. The growth rate of cerebellopontine angle (CPA) tumours (1.4 mm/year) was significantly greater than that of tumours limited to the internal auditory canal (IAC) (0.2 mm/year) (p = 0.001). Failure of conservative management, in which active treatment was required, occurred in 15.3%. The outcome of these patients appeared to be as favourable as those who underwent primary treatment, without a period of conservative management. The growth rate of tumours in patients who failed conservative management (4.2 mm/year) was significantly greater than that in patients who did not fail (0.5 mm/year) (p < 0.01). No factors predictive of tumour growth were identified. Deterioration of mean pure tone average (0.5, 1, 2, 3 kHz) and speech discrimination scores occurred regardless of whether radiological tumour growth was demonstrated or not. Conclusions: The majority of vestibular schwannomas are slow growing, although, CPA tumours appear to grow faster than IAC tumours. Deterioration of auditory function occurs even in the absence of tumour growth. Although most Otolaryngologists and Neurosurgeons would agree that the treatment of choice for the majority of vestibular schwannomas is microsurgery, there remains a small group of patients in whom a conservative management approach may be a desirable alternative.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE